Sigurdur Oli Olafsson Insider Profile
4 Followers
Sigurdur Oli Olafsson, Chief Executive Officer at Hikma Pharmaceuticals, holds 63.35K shares in Hikma Pharmaceuticals (Ticker: GB:HIK).
Sigurdur Oli Olafsson's Trading History
| HIKHikma Pharmaceuticals | Mar 15, 2022 | Chief Executive Officer | Uninformative Buy | ― | £1.06M | |||||||||||||||||||||||||||||||||||||||||||
GB:HIK Insider Shares: 63.35K (2.75%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Sigurdur Oli Olafsson insider profile FAQ
What is the percentage of profitable transactions made by Sigurdur Oli Olafsson?
The percentage of profitable transactions made by Sigurdur Oli Olafsson is 75%.
What is the average return per transaction made by Sigurdur Oli Olafsson?
The average return per transaction made by Sigurdur Oli Olafsson is 9.10%.
What stocks does Sigurdur Oli Olafsson hold?
Sigurdur Oli Olafsson holds: GB:HIK stocks.
What was Sigurdur Oli Olafsson's most profitable transaction?
Sigurdur Oli Olafsson’s most profitable transaction was an Informative Buy of GB:HIK stock on May 31, 2018. The return on the trade was 18.70%.
What is Sigurdur Oli Olafsson's role in Hikma Pharmaceuticals?
Sigurdur Oli Olafsson's role in Hikma Pharmaceuticals is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
